GSK insider Waterhouse to head drugmaker's HIV unit ViiV
December 05, 2016 at 09:36 AM EST
LONDON, Dec 5 (Reuters) - GlaxoSmithKline said on Monday that Dominique Limet would step down at the end of March 2017 as head of the drugmaker's majority-owned HIV business ViiV Healthcare, to be replaced by GSK insider Deborah Waterhouse.